Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 2.18 M1.8 M2.15 M-775 K2.03 M 5.21 M Research & development ————— — Operating income -5 M-8.56 M-12.49 M-9.95 M-8.78 M -39.77 M Non-Operating Income, Total -78 K-21 K636 K-7 00017 K 625 K Interest expense, net of interest capitalized 9.76 M10.18 M10.31 M9.95 M9.12 M 39.56 M Non-Operating Income, excl. Interest Expenses -9.84 M-10.2 M-9.68 M-9.95 M-9.11 M -38.93 M Unusual income/expense ————— — Pretax income -6.15 M-8.99 M-12.51 M-11.42 M-8.42 M -41.34 M Equity in earnings -1.15 M-437 K-697 K-1.48 M-1.38 M -3.98 M Taxes 121 K158 K74 K144 K0 376 K Non-controlling/minority interest -158 K-152 K-131 K-132 K-108 K -523 K After tax other income/expense ————— — Net income before discontinued operations -6.11 M-9 M-12.46 M-11.43 M-8.31 M -41.2 M Discontinued operations ————— — Net income -6.11 M-9 M-12.46 M-11.43 M-8.31 M -41.2 M Dilution adjustment -5.48 M-5.28 M-5.28 M-5.16 M-4.18 M -19.9 M Preferred dividends 300 K001.14 M22.21 M 23.34 M Diluted net income available to common stockholders -11.9 M-14.28 M-17.74 M-17.73 M-34.7 M -84.44 M Basic earnings per share (Basic EPS) -2 073-1 894-2 352-479-70.52 -4 795.52 Diluted earnings per share (Diluted EPS) -2 073-1 894-2 352-479-70.52 -4 795.52 Average basic shares outstanding 5 7407 5407 5409 190492 K — Diluted shares outstanding 5 7407 5407 5409 190492 K — EBITDA 1.63 M-2.26 M-5.14 M-3.03 M-1.06 M -11.49 M EBIT -5 M-8.56 M-12.49 M-9.95 M-8.78 M -39.77 M Cost of revenue 23.06 M23.15 M23.21 M23.04 M24.15 M 93.55 M Other cost of goods sold 17.13 M16.97 M16.14 M16.8 M17.15 M 67.06 M Depreciation & amortization (cash flow) 6.63 M6.29 M7.35 M6.92 M7.72 M 28.28 M